Twist Debt Equity Ratio from 2010 to 2024

TWST Stock  USD 48.32  1.98  4.27%   
Twist Bioscience Debt Equity Ratio yearly trend continues to be comparatively stable with very little volatility. Debt Equity Ratio is likely to outpace its year average in 2024. From the period from 2010 to 2024, Twist Bioscience Debt Equity Ratio quarterly data regression had r-value of  0.90 and coefficient of variation of (161.94). View All Fundamentals
 
Debt Equity Ratio  
First Reported
2010-12-31
Previous Quarter
0.0282
Current Value
0.0296
Quarterly Volatility
0.08478477
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Twist Bioscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Twist Bioscience's main balance sheet or income statement drivers, such as Tax Provision of 588 K, Net Interest Income of 16.1 M or Interest Income of 16.1 M, as well as many indicators such as Price To Sales Ratio of 7.96, Dividend Yield of 0.0 or PTB Ratio of 5.82. Twist financial statements analysis is a perfect complement when working with Twist Bioscience Valuation or Volatility modules.
  
Check out the analysis of Twist Bioscience Correlation against competitors.

Latest Twist Bioscience's Debt Equity Ratio Growth Pattern

Below is the plot of the Debt Equity Ratio of Twist Bioscience Corp over the last few years. It is Twist Bioscience's Debt Equity Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Twist Bioscience's overall financial position and show how it may be relating to other accounts over time.
Debt Equity Ratio10 Years Trend
Slightly volatile
   Debt Equity Ratio   
       Timeline  

Twist Debt Equity Ratio Regression Statistics

Arithmetic Mean(0.05)
Geometric Mean0.06
Coefficient Of Variation(161.94)
Mean Deviation0.08
Median(0.05)
Standard Deviation0.08
Sample Variance0.01
Range0.1968
R-Value0.90
Mean Square Error0
R-Squared0.81
Slope0.02
Total Sum of Squares0.10

Twist Debt Equity Ratio History

2024 0.0296
2023 0.0282
2022 0.0313
2021 0.0173
2020 0.0168
2019 0.0331
2018 0.0508

About Twist Bioscience Financial Statements

Twist Bioscience shareholders use historical fundamental indicators, such as Debt Equity Ratio, to determine how well the company is positioned to perform in the future. Although Twist Bioscience investors may analyze each financial statement separately, they are all interrelated. The changes in Twist Bioscience's assets and liabilities, for example, are also reflected in the revenues and expenses on on Twist Bioscience's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Debt Equity Ratio 0.03  0.03 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Twist Stock Analysis

When running Twist Bioscience's price analysis, check to measure Twist Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Twist Bioscience is operating at the current time. Most of Twist Bioscience's value examination focuses on studying past and present price action to predict the probability of Twist Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Twist Bioscience's price. Additionally, you may evaluate how the addition of Twist Bioscience to your portfolios can decrease your overall portfolio volatility.